SC 13G Filing

Company

Cellectar Biosciences, Inc.

Filed

April 11, 2016

Accession Number

0000315066-16-005755

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →